Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises one of Carl Lamm’s principal shareholders in relation to the public offer from Ricoh
Mandate

Vinge advises one of Carl Lamm’s principal shareholders in relation to the public offer from Ricoh

April 17, 2009

Vinge is advising one of Carl Lamm Holding AB’s principal shareholders in connection with the public offer from Ricoh Europe Holdings PLC. The offer, which comprises all shares in Carl Lamm, values Carl Lamm at approximately SEK 417 million. Carl Lamm is listed on NASDAQ OMX Stockholm.

Vinge’s advice is provided by Mattias Friberg.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026